Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues	$ 21,538	$ 21,911
Cost of revenues	12,782	9,228
Gross profit	8,756	12,683
Operating expenses:
General and administrative	10,276	5,981
Sales and marketing	11,631	6,118
Research and development	8,545	3,432
Total operating expenses	30,452	15,531
Operating loss	(21,696)	(2,848)
Other income (expense):
Interest expense, net	(226)	(417)
Preferred stock warrant liability adjustment	0	(4,608)
Common stock warrant liability adjustment	(6,876)	0
Other income (expense), net	47	21
Total other income (expense), net	(7,055)	(5,004)
Loss before income tax provision	(28,751)	(7,852)
Income tax provision	(7)	(5)
Net loss and comprehensive loss	$ (28,758)	$ (7,857)
Net loss per share attributable to common stockholders, basic (in dollars per share)	$ (0.26)	$ (0.35)
Net loss per share attributable to common stockholders, diluted (in dollars per share)	$ (0.26)	$ (0.35)
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, basic (in shares)	110,384,313	22,233,820
Weighted-average number of shares outstanding used to compute net loss per share attributable to common stockholders, diluted (in shares)	110,384,313	22,233,820